Logo Logo
Hilfe
Hilfe
Switch Language to English

Koletzko, Leandra; Macke, Lukas; Schulz, Christian und Malfertheiner, Peter (2019): Helicobacter pylori eradication in dyspepsia: New evidence for symptomatic benefit. In: Best Practice & Research Clinical Gastroenterology, Bd. 40-41, 101637

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

A causal relationship between Helicobacter pylori (H. pylori) infection and functional dyspepsia (FD) is well established in a subset of infected patients. In the Kyoto and Maastricht/Florence consensus reports H. pylon-associated dyspepsia is defined as an independent entity distinct from FD. H. pylori eradication is therefore the most cost-effective approach for infected patients with dyspeptic symptoms and superior to other medical therapies, such as Proton Pump Inhibitors. The therapeutic gain of H.pylori eradication for symptom relief compared to other therapeutic options is significant with the number needed to benefit of 12. Furthermore H.pylori cures chronic gastritis except in severe cases of atrophic gastritis and may prevent severe complications attributable to the infection. Several pathophysiological mechanisms are suggested for the generation of symptoms and are related to the distinct topographic expression and degree of gastric inflammation as well as changes of gastric acid secretion, gastrointestinal motility and visceral hypersensitivity. (C) 2019 Published by Elsevier Ltd.

Dokument bearbeiten Dokument bearbeiten